Epilepsy
GLP-1 diabetes drugs tied to modestly lower epilepsy risk in large study
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
Preliminary research published in Neurology suggests that GLP-1 medications, including drugs such as Ozempic, may be associated with a modestly lower risk of developing epilepsy in people with type 2 diabetes compared with DPP-4 inhibitors. In the analysis, GLP-1 users were 16 percent less likely to develop epilepsy after statistical adjustment, but researchers stress that the findings show an association, not proof of cause and effect.
The Neurobiochemistry Laboratory at AIIMS Delhi has launched a new Therapeutic Drug Monitoring facility to improve epilepsy care. The service aims to provide affordable testing for patients across India. Officials said it will help optimise treatment and reduce reliance on costly private labs.
AI에 의해 보고됨
A team of doctors from public and private sectors conducted free epilepsy surgeries at Groote Schuur Hospital in Cape Town on 21 February 2026, helping two patients who had waited two years. The Rise initiative aims to provide regular surgical care for drug-resistant epilepsy in the public health system. Funding came from Gift of the Givers, covering nursing staff costs.